Rx · PZN 11329803, 11329849, 12868614, 13235466…
NUCALA 100 mg powder for preparation of a solution for injection
German trade nameNUCALA 100 mg Pulver zur Herstellung einer Injektionslösung
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for NUCALA 100 mg powder for preparation of a solution for injection.
Review purchasing termsNUCALA 100 mg powder for preparation of a solution for injection contains the active ingredient Mepolizumab. 13 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
Pack sizes · 13 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 11329803 | 0.0 | 0.0 | ~ €1,000 |
| 11329849 | 0.0 | 0.0 | ~ €2,998 |
| 12868614 | 0.0 | 0.0 | ~ €1,000 |
| 13235466 | 0.0 | 0.0 | ~ €2,994 |
| 13352597 | 0.0 | 0.0 | ~ €1,000 |
| 13352605 | 0.0 | 0.0 | ~ €2,998 |
| 12481625 | 0.0 | 0.0 | ~ €1,000 |
| 12481631 | 0.0 | 0.0 | ~ €2,934 |
| 13357577 | 0.0 | 0.0 | ~ €1,000 |
| 16144787 | 0.0 | 0.0 | ~ €1,000 |
| 15815481 | 0.0 | 0.0 | ~ €2,994 |
| 14227581 | 0.0 | 0.0 | ~ €1,000 |
| 14309824 | 0.0 | 0.0 | ~ €2,994 |
According to the data available to us, NUCALA 100 mg powder for preparation of a solution for injection is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply